20551 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters; Glycosaminoglycans, i.e. mucopolysaccharides Hyaluronic acid
Method of ophthalmic surgery and kit therefor
#1502USE OF HYALURONIC ACID AS A CARRIER MOLECULE FOR DIFFERENT CLASSES OF THERAPEUTIC ACTIVE AGENTS
#1503Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
#1504Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
#1505Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
#1506ORAL AGENT FOR IMPROVING AND PROTECTING THE FUNCTION OF JOINT COMPRISING HYALURONIC ACID-PHOSPHOLIPID COMPLEXES
#1507Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
#1508Hyaluronic Acid Binary Mixtures and Therapeutic Use Thereof
#1509Method for Purification of Hyaluronic Acid Salt
#1510Hydrazido derivatives of hyaluronic acid
#1511Polysaccharide gel formulation having increased longevity
#1512ENGINEERED INTERVERTEBRAL DISC TISSUE
#1513Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
#1514Biologically active peptide and agent containing the same
#1515Anti-adhesion composites and methods of use thereof
#1516Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate and use of calcium chelating agent and ophthalmologically compatible viscosity regulator
#1517Treatment and prevention of joint disease
#1518ACETAMINOPHEN FORMULATION FOR JOINT PAIN RELIEF
#1519METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#1520Treatment with Kallikrein Inhibitors
#1521Wound-Healing Composition
#1522METHOD OF TREATING CANCER AND/OR CELLULAR PROLIFERATIVE CONDITIONS AND AGENTS TARGETING HYALURONAN ANABOLISM USEFUL FOR SAME
#1523Therapeutic protocols using hyaluronan
#1524Pharmaceutical compositions for treating or preventing bone conditions
#1525Stabilized glycosaminoglycan preparations and related methods
#1526PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTHRITIS CONTAINING CLODRONIC ACID AND HYALURONIC ACID
#1527METHODS FOR CELL MOBILIZATION USING IN VIVO TREATMENT WITH HYALURONAN (HA)
#1528METHOD AND COMPOUND FOR THE TREATMENT OF ARTICULAR DISEASES OR ARTICULAR PAIN, OR FOR THE TREATMENT OF SKIN FOR AESTHETIC OR OTHER PURPOSES, AND THE METHOD OF PREPARATION OF THE COMPOUND
#1529METHOD FOR RESTORING A DAMAGED OR DEGENERATED INTERVERTEBRAL DISC
#1530METHODS FOR CELL MOBILIZATION USING IN VIVO TREATMENT WITH HYALURONAN (HA)
#1531METHOD OF TREATMENT USING MICROPARTICULATE BIOMATERIAL COMPOSITION
#1532COMPOSITIONS COMPRISING POLYCATION-COMPLEXED PROTEIN CRYSTALS AND METHODS OF TREATMENT USING THEM
#1533Coated Hyaluronic Acid Particles
#1534Phamaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith
#1535Promoter For Hard Tissue Formation
#1536NUTRACEUTICAL COMPOSITIONS AND METHODS WITH BIOLOGICALLY ACTIVE INGREDIENTS
#1537Bismuth hyaluronate, the preparation method and the use thereof
#1538Methods for treating a wound using epidermal growth factor formulation
#1539Method for micro-incision cataract surgery, a method of evaluation of a viscoelastic material, a composition for evaluation of a viscoelastic material and a method for evaluation using the composition
#1540Agent for Applying to Mucosa and Method for the Production Thereof
#1541Methods of administering diclofenac compositions for treating photodamaged skin, rosacea and/or acne
#1542Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
#1543KINESIN INHIBITORS
#1544Wound-Healing Pharmaceutical Compositions in the Form of a Cream Based on Amino Acids and Sodium Hyaluronate
#1545Compositions and Methods for Viscosupplementation
#1546Composition for restoration of age related tissue loss in the face or selected areas of the body
#1547Beauty/medication patch
#1548Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug
#1549Chitosan-Based Particles
#1550Therapeutic agents and therapeutic methods for treating injured tissue
#1551Ophthalmic Pharmaceutical Compositions Based on Amino Acids and Sodium Hyaluronate
#1552Methods and compositions for intraocular administration to treat ocular conditions
#1553Medicinal composition for ophthal use containing acetylated hyaluronic acid
#1554Hyaluronic acid derivative and drug containing the same
#1555Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
#1556Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
#1557METHODS AND COMPOSITIONS TO TREAT MYOCARDIAL CONDITIONS
#1558Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
#1559Antiproliferative Drug
#1560Use of lipid conjugates in the treatment of diseases
#1561Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
#1562Methods for administering FGF18
#1563Composition for treating inflammatory diseases
#1564HYALURONIC ACID OLIGOSACCHARIDE FRACTIONS AND DRUGS CONTAINING THE SAME
#1565Perfusive Organ Hemostasis
#1566Agent for drug clearance and accelerator for drug clearance
#1567Method of treating articular pain using a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan
#1568VITREOUS BODY VISUALIZATION AGENT
#1569RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
#1570RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
#1571RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
#1572Hyaluronic Acid Linked With a Polymer of an Alpha Hydroxy Acid
#1573Separate type medical material
#1574Methods of selectively treating diseases with specific glycosaminoglycan polymers
#1575OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF
#1576Device and methods of sequential, regional delivery of multiple cyctotoxic agents and directed assembly of wound repair tissues
#1577Hyaluronate compositions
#1578COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE MUCOSAE, SKIN AND THE EYE
#1579Compositions and methods for transdermal joint pain therapy
#1580Methods using glycosaminoglycans for the treatment of nephropathy
#1581Amide derivatives of hyaluronic acid in osteoarthrosis
#1582Composition based on salts of hyaluronic acid for treating epithelial lesions
#1583COMPOSITIONS WITH SEVERAL HYALURONIC ACID FRACTIONS FOR COSMETIC USE
#1584Hyaluronan used in improvement of anti-oxidation and proliferation in chondrocytes
#1585Substances, Compositions, and Methods for Treating Alopecia
#1586Fluidic Tissue Augmentation Compositions and Methods
#1587THIOLATED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF
#1588TOPICALLY APPLIED PROBUCOL-CONTAINING AGENT WITH PROTECTIVE AND REGENERATIVE EFFECT
#1589Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye
#1590Injectable collagen material
#1591Composition and method for treating connective tissue damage
#1592Hydrolysate of avian cartilage, process of preparation and uses thereof
#1593Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury
#1594Hydrophobic biomolecular structure
#1595Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
#1596Combinations of Hyaluronic Acid and Polyunsaturated Fatty Acids
#1597Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
#1598Compositions and methods for viscosupplementation
#1599Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
#1600Acetaminophen formulation for joint pain relief
#1601Energy assisted stem cell extract
#1602Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal Degeneration
#1603Hyaluronic acid-based cross-linked nanoparticles
#1604Nonexpansion Protocol for Autologous Cell-Based Therapies
#1605COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS UTILIZING PROTEIN OR POLYSACCHARIDE CONTAINING ANTI-MICROTUBULE AGENTS
#1606Fluidic Tissue Augmentation Compositions and Methods
#1607Antioxidant compositions for the eye
#1608Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
#1609ANTI-AGEING COMPOSITION
#1610Apparatus and formulations for suprachoroidal drug delivery
#1611Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
#1612Taste-masked drugs in rupturing multiparticulates
#1613Compositions for the treatment of osteoarthritis and to nourish the synovial fluid
#1614Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
#1615Use of lipid conjugates in cystic fibrosis and applications thereof
#1616Non-glycerol stabilized bone graft
#1617METHODS FOR ENHANCING SKIN TREATMENTS
#1618Methods Using Sulodexide for the Treatment of Bladder Disease
#1619Transluminal drug delivery methods and devices
#1620Transluminal drug delivery methods and devices
#1621Use of lipid conjugates in the treatment of conjunctivitis
#1622Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
#1623HYALURONIC ACID MEDIATED ADENOVIRAL TRANSDUCTION
#1624Hyaluronic acid oligosaccharide fractions and drugs containing the same
#1625Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
#1626Use of lipid conjugates in the treatment of disease
#1627Integument cell regeneration formulation
#1628Fertility and anti-aging supplement for the fertility health of females and males
#1629Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
#1630Drug having regulatory cell ligand contained in liposome
#1631Pharmaceutical agent containing hyaluronan as an active ingredient
#1632Injection vehicle for polymer-based formulations
#1633Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
#1634Use of lipid conjugates in the treatment of disease
#1635Compositions and methods for improved skin care
#1636Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#1637Compositions and methods for the treatment of wounds and the reduction of scar formation
#1638Agents for controlling biological fluids and methods of use thereof
#1639BI-MODAL HYALURONATE
#1640Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis
#1641Composition for reduction of scar formation on wound scar
#1642Composition and method for the repair and regeneration of cartilage and other tissues
#1643Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
#1644Blood soluble drag reducing hyaluronic acid
#1645Treatment of leg ulcers using placenta derived collagen biofabric
#1646Composition and method for the treatment of psoriasis
#1647Method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration and method for promoting neurogenesis
#1648Treatment with hyaluronic acid
#1649Use of lipid conjugates in the treatment of disease
#1650Injectable Osteogenic Formula and Method of Using Same
#1651Compositions for treating osteoarthritis
#1652Hyaluronan-chemotherapeutic agent formulations for the treatment of colon cancer
#1653Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
#1654NUTRITIONAL COMPOSITION AND METHODS OF MAKING AND USING SAME
#1655Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
#1656Methods of tissue repair and compositions therefor
#1657Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging
#1658Polycationic peptide coatings and methods of coating implantable medical devices
#1659Ceramic composition for filling bone defects
#1660Topical compositions and methods for treating pain and inflammation
#1661Formulations of peptides for periodontal and dental treatments
#1662Blend hydrogels and methods of making
#1663Preparation of low molecular weight hyaluronic acid as a food supplement
#1664Stabilized compositions for topical administration and methods of making same
#1665Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof
#1666Hyaluronan as a chemo-sensitizer in the treatment of cancer
#1667Method for producing alkyl-esterified glycosaminoglycan
#1668Biologically active peptide and agent containing the same
#1669Freeze-dried fibrin matrices and methods for preparation thereof
#1670Plant producing hyaluronic acid
#1671Medicinal composition for ophthal use containing acetylated hyaluronic acid
#1672Hyaluronic acid derivative gel and method for preparing the same
#1673Engineered intervertebral disc tissue
#1674Tamponade compositions and methods for retinal repair
#1675Hair regenerator
#1676Wound dressing materials comprising complexes of anionic polysaccharides with silver
#1677Regimens for intra-articular viscosupplementation
#1678Composition and method for treatment of joint damage
#1679Separate type medical material
#1680Therapeutic agent for nerve damage
#1681Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents
#1682Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
#1683Pharmaceutical composition and method for treating a joint-capsule arthropathy
#1684Combination preparation of hyaluronic acid and at least oe local anesthetic and the use thereof
#1685Polymer grafting by polysaccharide synthases
#1686Triple natural polymer viscoelastic composition
#1687Ophthalmic compositions and methods for treating eyes
#1688Medical composition for protuberance of epithelium
#1689Antipruritic composition for external use on skin
#1690Process for preparing crosslinked hyaluronic acid gel
#1691Ophthalmic and ophthalmological use of a complex nutritive base in aqueous medium
#1692Ophthalmic solution
#1693Hyaluronic acid in the enhancement of lens regeneration
#1694Protein biomaterials and biocoacervates and methods of making and using thereof
#1695Method and composition for restoration of age related tissue loss in the face or selected areas of the body
#1696Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using hyaluronic acid
#1697Methods of administering diclofenac compositions for treating rosacea
#1698Flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time
#1699Process for preparing a sterile high molecular weight hyaluronic acid formulation
#1700Joint therapy
#1701Aesthetic use of hyaluronan
#1702Compositions and methods using hyaluronic acid
#1703Composition and method for the repair and regeneration of cartilage and other tissues
#1704Stabilized hyaluronan preparations and related methods
#1705Dose dependent elimination of HA and cell receptor stimulation
#1706Polymer gel containing hyaluronic acid and collagen, and its use in joints
#1707Polycationic peptide coatings and methods of coating implantable medical devices
#1708Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
#1709Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair
#1710Dilution resistant viscoelastic compositions
#1711Topical compositions for anti-aging and methods of using same
#1712Hyaluronic acid in the enhancement of lens regeneration
#1713Polycationic peptide coatings and methods of coating implantable medical devices
#1714Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
#1715Non-aspirating transitional viscoelastics for use in surgery
#1716Drugs against articular failure
#1717Methods of selectively treating diseases with specific glycosaminoglycan polymers
#1718Fast dissolving dried hyaluronic acid product
#1719Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease
#1720Dried and agglomerated hyaluronic acid product
#1721Contact lens and eye drop rewetter compositions and methods
#1722Contact lens and eye drop rewetter compositions and methods
#1723Hydrophobic biomolecular structure
#1724Human body affinitive lubricating protective and repair gel
#1725Hyaluronic acid based copolymers
#1726Use of mixture of sodium hyaluronate and chondroitin sulfate for use in products and therapies for cosmetic surgery
#1727Hyaluronic acid derivatives
#1728Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
#1729Combinations of viscoelastics for use during surgery
#1730Re-epithelializing pharmaceutical compositions comprising xanthan gum
#1731Local regional chemotherapy and radiotherapy using in situ hydrogel
#1732Methods using glycosaminoglycans for the treatment of nephropathy
#1733Local regional chemotherapy and radiotherapy using in situ hydrogel
#1734Carboxyl-reduced derivatives of hyaluronic acid, preparation thereof, use thereof as a medicinal product and the pharmaceutical compositions containing them
#1735Prevention of loss of tight cell junctions using carbohydrate-containing compositions
#1736Ceramide formulations suitable for oral administration
#1737Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
#1738Pharmaceutical applications of hyaluronic acid preparations
#1739Chondroprotective/restorative compositions and methods of use thereof
#1740Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
#1741Hyaluronic acid modification product
#1742Pharmaceutical composition for ophthalmological and rhinological application
#1743Liquid, eye-instillable preparations comprising sodium hyaluronate
#1744Methods of administering diclofenac compositions for treating photodamaged skin, rosacea and/or acne
#1745Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
#1746Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
#1747Modified hyaluronic acid for use in musculoskeletal tissue repair
#1748Modifying tissue surfaces by liquid crystal formation
#1749Nasal composition comprising a mucopolysaccharide and propylene glycol
#1750Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
#1751Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
#1752Pharmaceutical composition for the treatment of rhinitis
#1753Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
#1754Compositions for promoting vaginal cell proliferation and maturation
#1755Hyaluronic acid oligosaccharide fractions and drugs containing the same
#1756Health food containing hyaluronic acid and dermatan sulfate
#1757Methods for treating acute and overuse sprain and strain using hyaluronic acid
#1758Method of modulating release of saccharides and uses thereof
#1759Process for causing myopic shift in vision
#1760Compositions and methods for inhibiting slit protein and glypican interactions
#1761Heparin-containing ophthalmic agent
#1762Agent for treating inflammatory bowel diseases
#1763Solubility and Absorption Promoter
#1764Therapeutic protocols
#1765Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
#1766Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
#1767Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
#1768Composition for improving respiratory health of companion animals
#1769Delayed release oral pharmaceutical composition
#1770Compositions and methods of treatment for various conditions using high-molecular weight hyaluronic acid
#1771Agmatine compositions for treatment of osteoarthritis
#1772Method of lubricating bodily tissue using an amnion derived therapeutic composition
#1773Treatment of connective tissue injuries
#1774COVID-19 treatment and methods
#1775Nutraceutical dietary supplement
#1776Glycosaminoglycans from
#1777Hyaluronic acid formulation
#1778Hyaluronic acid formulation
#1779Method of administering hyaluronan formulation for maintaining and supporting joint health
#1780Method of administering hyaluronan formulation for supporting joint health
#1781Hyaluronan-containing composition and use thereof for mitigation and/or prevention of inflammation and/or pain
#1782Composition for an anti-aging treatment
#1783Composition for healing skin
#1784Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis
#1785Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis
#1786Method of administering hyaluronan formulation for the amelioration of osteophytes